Filter
176
Filtered Results: 176
Text search:
National
Leprosy
Eradication
Programme
Featured
Recommendations
11
New Publications
80
Language
Document type
No document type
126
Studies & Reports
21
Strategic & Response Plan
14
Guidelines
11
Manuals
4
Countries / Regions
India
41
Nepal
8
Sierra Leone
8
Global
7
Liberia
7
Kenya
6
Myanmar / Burma
6
Bangladesh
5
Namibia
5
Ghana
4
Uganda
4
Zambia
4
Indonesia
4
Nigeria
3
Africa
3
Ethiopia
3
Zimbabwe
2
Guinea
2
Tanzania
2
South Africa
2
Timor Leste/ East Timor
1
Lesotho
1
Cameroon
1
Malawi
1
Philippines
1
Haiti
1
Latin America and the Carribbean
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Southern Africa
1
Botswana
1
South Sudan
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
112
Public Health
12
Clinical Guidelines
12
Key Resources
3
Women & Child Health
2
Capacity Building
1
Toolboxes
NTDs
28
Disability
11
TB
6
AMR
4
Rapid Response
3
Ebola & Marburg
3
NCDs
3
HIV
2
Caregiver
2
Conflict
2
Specific Hazards
1
COVID-19
1
Health Financing Toolbox
1
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution...
This document provides guidance for countries on how to implement activities to achieve the interruption of yaws transmission. It is intended for use by national yaws eradication programmes, partners involved in the implementation of yaws eradication activities and WHO technical staff who provide te...
Towards Universal Access to Prevention, Diagnosis and Treatment
Yaws is a disfiguring non-venereal disease caused by infection with the spirochaete. Treponema pallidum subspecies pertenue which is closely related to the causative agent of syphilis and those of the other endemic treponematoses, bejel and pinta. The disease is endemic in certain areas of the World...
A National Service Programme for All Children with Special Needs and their Families
In Myanmar, we estimate that at least 40% of children require ECI services for short to longer periods of time. At present, 35.1% of Myanmar children are moderately to severely stunted; all of these children are l...
In Myanmar, we estimate that at least 40% of children require ECI services for short to longer periods of time. At present, 35.1% of Myanmar children are moderately to severely stunted; all of these children are l...
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und...
This document sets out the criteria and procedures to be followed by countries in verifying the interruption of yaws transmission. It is intended for use by international verification teams, national yaws eradication programmes and WHO technical staff involved in the eradication of yaws.
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...
In May the Sixty-sixth World Health Assembly adopted resolution WHA66.12 (1) on 17 neglected tropical diseases (NTDs). Among other measures, the resolution urges Member States to:
• ensure country ownership of prevention, control, elimination and eradication programmes;
• expand and implemen...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra...
Final report 2016
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
